BJ
RVNC

BlackRock Japan’s Revance Therapeutics, Inc. RVNC Stock Holding History

BlackRock Japan’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,126
Closed -$36K – 1371
2015
Q2 		$36K Buy
+1,126
New +$29K ﹤0.01% 1124
2014
Q3 		– Sell
-2,332
Closed -$79K – 1326
2014
Q2 		$79K Buy
2,332
+171
+8% +$5.36K ﹤0.01% 975
2014
Q1 		$68K Buy
+2,161
New +$67.5K ﹤0.01% 1118

Other funds holding RVNC

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NHG
NQ HCIF GP Raleigh, North Carolina $50.2M AUM 45.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Japan's RVNC Position: Q3 2015 in Review

BlackRock Japan sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2015, closing a stake of 1,126 shares — an estimated $36K sold.

BlackRock Japan first reported a position in RVNC in Q1 2014 and held it in 3 quarters. The position peaked at $79K in Q2 2014. 79 funds tracked by Wall St. Rank hold RVNC as of Q3 2015.

  • BlackRock Japan reported no remaining Revance Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • BlackRock Japan sold 1,126 Revance Therapeutics, Inc. shares in Q3 2015, an estimated $36K.
  • BlackRock Japan first reported a position in Revance Therapeutics, Inc. in Q1 2014 and held it in 3 quarters.
  • BlackRock Japan's Revance Therapeutics, Inc. position peaked at $79K in Q2 2014.
  • 79 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2015.

Based on BlackRock Japan's 13F filing for Q3 2015, filed 13 Nov 2015.